Literature DB >> 31598967

Hydroxycarbamide and white matter integrity in pediatric sickle cell disease: Commentary to accompany: Hydroxycarbamide treatment in children with sickle cell anaemia is associated with more intact white matter integrity: a quantitative MRI study.

Eboni I Lance1,2, Lori C Jordan3.   

Abstract

Entities:  

Keywords:  hydroxycarbamide; pediatric sickle cell disease; white matter integrity

Mesh：

Substances：

Year:  2019        PMID： 31598967      PMCID： PMC6800718          DOI： 10.1111/bjh.16252

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  17 in total

1.  White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.

Authors:  B Sun; R C Brown; L Hayes; T G Burns; J Huamani; D J Bearden; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

2.  Parent education and biologic factors influence on cognition in sickle cell anemia.

Authors:  Allison A King; John J Strouse; Mark J Rodeghier; Bruce E Compas; James F Casella; Robert C McKinstry; Michael J Noetzel; Charles T Quinn; Rebecca Ichord; Michael M Dowling; J Philip Miller; Michael R Debaun
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

Review 3.  Central nervous system complications and management in sickle cell disease.

Authors:  Michael R DeBaun; Fenella J Kirkham
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

4.  PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE.

Authors:  Michael R Debaun; Najibah A Galadanci; Adetola A Kassim; Lori C Jordan; Sharon Phillips; Muktar H Aliyu
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

5.  The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study.

Authors:  Przemyslaw D Kosinski; Paula L Croal; Jackie Leung; Suzan Williams; Isaac Odame; Gregory M T Hare; Manohar Shroff; Andrea Kassner
Journal:  Br J Haematol       Date:  2016-12-01       Impact factor: 6.998

6.  Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study.

Authors:  Daniel Kapustin; Jackie Leung; Isaac Odame; Suzan Williams; Manohar Shroff; Andrea Kassner
Journal:  Br J Haematol       Date:  2019-06-18       Impact factor: 6.998

7.  Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Authors:  Mark T Gladwin; Alan N Schechter; Frederick P Ognibene; Wynona A Coles; Christopher D Reiter; William H Schenke; Gyorgy Csako; Myron A Waclawiw; Julio A Panza; Richard O Cannon
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 8.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

9.  Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Authors:  Russell E Ware; Barry R Davis; William H Schultz; R Clark Brown; Banu Aygun; Sharada Sarnaik; Isaac Odame; Beng Fuh; Alex George; William Owen; Lori Luchtman-Jones; Zora R Rogers; Lee Hilliard; Cynthia Gauger; Connie Piccone; Margaret T Lee; Janet L Kwiatkowski; Sherron Jackson; Scott T Miller; Carla Roberts; Matthew M Heeney; Theodosia A Kalfa; Stephen Nelson; Hamayun Imran; Kerri Nottage; Ofelia Alvarez; Melissa Rhodes; Alexis A Thompson; Jennifer A Rothman; Kathleen J Helton; Donna Roberts; Jamie Coleman; Melanie J Bonner; Abdullah Kutlar; Niren Patel; John Wood; Linda Piller; Peng Wei; Judy Luden; Nicole A Mortier; Susan E Stuber; Naomi L C Luban; Alan R Cohen; Sara Pressel; Robert J Adams
Journal:  Lancet       Date:  2015-12-06       Impact factor: 79.321

10.  White matter integrity and processing speed in sickle cell anemia.

Authors:  Hanne Stotesbury; Fenella J Kirkham; Melanie Kölbel; Philippa Balfour; Jonathan D Clayden; Sati Sahota; Simrat Sakaria; Dawn E Saunders; Jo Howard; Rachel Kesse-Adu; Baba Inusa; Maria Pelidis; Subarna Chakravorty; David C Rees; Moji Awogbade; Olu Wilkey; Mark Layton; Christopher A Clark; Jamie M Kawadler
Journal:  Neurology       Date:  2018-05-11       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.